SCHEMBL305527

SCHEMBL305527

O=C1c2ccccc2C(=O)c2cc(S(=O)(=O)[O-])ccc21.[Na+]

nearest known ligand 0.62

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PKLR P30613 4/20 0.62
▸ PARG Q86W56 6/20 0.59
▸ SMN1; SMN2 Q16637 3/20 0.56
▸ KMT2A Q03164 3/20 0.56
▸ MEN1 O00255 2/20 0.56
▸ MAPK1 P28482 2/20 0.56
▸ MAPT P10636 1/20 0.56
▸ PKM P14618 1/20 0.56
▸ HTT P42858 1/20 0.56
▸ ELANE P08246 1/20 0.50
▸ FTO Q9C0B1 1/20 0.50
▸ STAT3 P40763 1/20 0.50
▸ CDC25B P30305 1/20 0.50
▸ NPC1 O15118 1/20 0.50
▸ ALDH1A1 P00352 1/20 0.50
▸ TP53 P04637 1/20 0.50
▸ CYP3A4 P08684 1/20 0.50
▸ TSHR P16473 1/20 0.50
▸ RAB9A P51151 1/20 0.50
▸ TDP1 Q9NUW8 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32662068 1.00 PKLR (0.62) PKLRPARGSMN1; SMN2KMT2AMEN1
SCHEMBL29384291 1.00 PKLR (0.62) PKLRPARGSMN1; SMN2KMT2AMEN1
SCHEMBL28367628 1.00 PKLR (0.62) PKLRPARGSMN1; SMN2KMT2AMEN1
Water SCHEMBL30203790 0.98 PKLR (0.60) PKLRPARGSMN1; SMN2KMT2AMEN1
Water SCHEMBL1976332 0.98 PKLR (0.60) PKLRPARGSMN1; SMN2KMT2AMEN1
Potassium Ion SCHEMBL2784885 0.96 PARG (0.59) PKLRPARGSMN1; SMN2KMT2AMEN1
SCHEMBL2858677 0.96 PARG (0.59) PKLRPARGSMN1; SMN2KMT2AMEN1
SCHEMBL9235321 0.96 PARG (0.59) PKLRPARGSMN1; SMN2KMT2AMEN1
SCHEMBL8985955 0.96 PARG (0.59) PKLRPARGSMN1; SMN2KMT2AMEN1
Silver SCHEMBL11327330 0.96 PARG (0.59) PKLRPARGSMN1; SMN2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1241 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250387524-A1 METHOD AND SYSTEM FOR THE PRODUCTION OF DISINFECTION AND/OR STERILISATION SOLUTIONS ESTEVEZ COMPANY CARLOS (ES) 2025-12-25 — — US claimed
US-20250243606-A1 ANTIBACTERIAL AND ANTIVIRAL FABRICS UNIV CALIFORNIA (US) 2025-07-31 — — US claimed
WO-2025097461-A1 METHOD FOR PREPARING QUINONE-MEDIATOR-MODIFIED BIOCHAR MATERIAL AND GRANULATION REACTION DEVICE 哈尔滨工业大学水资源国家工程研究中心有限公司 2025-05-15 — — WO claimed
EP-4549429-A1 METHOD AND SYSTEM FOR THE PRODUCTION OF DISINFECTION AND/OR STERILISATION SOLUTIONS Universitat Jaume I (ES) 2025-05-07 — — EP claimed
CN-119947554-A Perovskite layer, manufacturing method thereof and solar cell 香港城市大学 2025-05-06 — — CN claimed
US-20250143173-A1 PEROVSKITE LAYER, FABRICATION METHOD AND USE THE SAME CITY UNIVERSITY OF HONG KONG (HK) 2025-05-01 — — US claimed
US-12270127-B2 Antibacterial and antiviral fabrics THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-04-08 — — US claimed
CN-115626964-B Ester ether copolymerization type polycarboxylate superplasticizer for recycled aggregate concrete and preparation method thereof 陕西科之杰新材料有限公司 2025-02-11 — — CN claimed
CN-117757432-B High-suspension grinding fluid suitable for large-size silicon wafer, preparation method and application 江苏奥首材料科技有限公司 2025-01-03 — — CN claimed
CN-118874513-A Photocatalyst, preparation method thereof and application of anthraquinone-2-sodium sulfonate in promoting degradation of azo dye by photocatalyst 福州大学 2024-11-01 — — CN claimed
EP-0233599-A1 Polymerization of chloroprene BAYER AG (DE) 1987-08-26 — — EP claimed
US-4678848-A TETRAALKYLTHIURAM DISULFIDE FOR WEIGHT CONTROL E. I. DU PONT DE NEMOURS AND COMPANY (US) 1987-07-07 — — US claimed
US-4617250-A DIAZO RESIN, HIGH MOLECULAR WEIGHT ACID-CONTAINING COMPOUND, AROMATIC SULFONATE, AND ORGANIC DYE FUJI PHOTO FILM CO., LTD. (JP) 1986-10-14 — — US claimed
US-4525561-A Polymerizing phenothiazine stabilizer chloroprene in the presence of an initiator comprising sodium dithionate BAYER AKTIENGESELLSCHAFT (DE) 1985-06-25 — — US claimed
EP-0057905-B1 DYESTUFF PREPARATIONS AND THEIR USE HOECHST AKTIENGESELLSCHAFT (DE) 1984-06-13 — — EP claimed
US-4356301-A Polyacetylene with anthraquinone system ROHM AND HAAS COMPANY (US) 1982-10-26 — — US claimed
EP-0057905-A1 Dyestuff preparations and their use HOECHST AKTIENGESELLSCHAFT (DE) 1982-08-18 — — EP claimed
EP-0055057-A2 Reducing polyacetylene crosslinking and embrittlement ROHM AND HAAS COMPANY (US) 1982-06-30 — — EP claimed
US-4168352-A SEMIPERMEABLE MEMBRANES IN LEAD-ACID BATTERIES COMPAGNIE GENERALE D'ELECTRICITE (FR) 1979-09-18 — — US claimed
US-4088441-A Dyestuff composition for the dyeing or printing of cellulose fiber materials HOECHST AKTIENGESELLSCHAFT (DT) 1978-05-09 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250143173-A1 PEROVSKITE LAYER, FABRICATION METHOD AND USE THE SAME KCNQ1, KCNQ2, SCNN1B PKLR 1737/4885PARG 3036/4885SMN1; SMN2 4579/4885
US-20250387524-A1 METHOD AND SYSTEM FOR THE PRODUCTION OF DISINFECTION AND/OR STERILISATION SOLUTIONS HAO2, PDK3, ADH1C PKLR 134/4885PARG 1134/4885SMN1; SMN2 4422/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback